WallStSmart

Tenet Healthcare Corporation (THC)vsUS Physicalrapy Inc (USPH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Tenet Healthcare Corporation generates 2656% more annual revenue ($21.31B vs $773.34M). THC leads profitability with a 6.6% profit margin vs 5.1%. USPH appears more attractively valued with a PEG of 2.64. THC earns a higher WallStSmart Score of 66/100 (B-).

THC

Strong Buy

66

out of 100

Grade: B-

Growth: 6.0Profit: 7.5Value: 7.3Quality: 6.3
Piotroski: 6/9Altman Z: 1.67

USPH

Buy

58

out of 100

Grade: C

Growth: 7.3Profit: 5.0Value: 2.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

THCUndervalued (+68.8%)

Margin of Safety

+68.8%

Fair Value

$724.93

Current Price

$200.04

$524.89 discount

UndervaluedFair: $724.93Overvalued
USPHSignificantly Overvalued (-39.3%)

Margin of Safety

-39.3%

Fair Value

$63.28

Current Price

$74.96

$11.68 premium

UndervaluedFair: $63.28Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

THC3 strengths · Avg: 8.3/10
Return on EquityProfitability
27.0%9/10

Every $100 of equity generates 27 in profit

P/E RatioValuation
12.9x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
27.6%8/10

Earnings expanding 27.6% YoY

USPH2 strengths · Avg: 8.0/10
Price/BookValuation
2.4x8/10

Reasonable price relative to book value

EPS GrowthGrowth
23.6%8/10

Earnings expanding 23.6% YoY

Areas to Watch

THC3 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.674/10

Distress zone — elevated risk

Profit MarginProfitability
6.6%3/10

6.6% margin — thin

PEG RatioValuation
4.692/10

Expensive relative to growth rate

USPH4 concerns · Avg: 2.8/10
Market CapQuality
$1.12B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
7.6%3/10

ROE of 7.6% — below average capital efficiency

Profit MarginProfitability
5.1%3/10

5.1% margin — thin

PEG RatioValuation
2.642/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : THC

The strongest argument for THC centers on Return on Equity, P/E Ratio, EPS Growth.

Bull Case : USPH

The strongest argument for USPH centers on Price/Book, EPS Growth. Revenue growth of 12.5% demonstrates continued momentum.

Bear Case : THC

The primary concerns for THC are Altman Z-Score, Profit Margin, PEG Ratio.

Bear Case : USPH

The primary concerns for USPH are Market Cap, Return on Equity, Profit Margin. A P/E of 52.0x leaves little room for execution misses.

Key Dynamics to Monitor

THC carries more volatility with a beta of 1.41 — expect wider price swings.

USPH is growing revenue faster at 12.5% — sustainability is the question.

THC generates stronger free cash flow (367M), providing more financial flexibility.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

THC scores higher overall (66/100 vs 58/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Tenet Healthcare Corporation

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Tenet Healthcare Corporation is a diversified health services company. The company is headquartered in Dallas, Texas.

US Physicalrapy Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

US Physical Therapy, Inc. operates outpatient physical therapy clinics that provide preoperative and postoperative care and treatment for orthopedic-related disorders, sports-related injuries, preventive care, injured worker rehabilitation, and neurology-related injuries. The company is headquartered in Houston, Texas.

Want to dig deeper into these stocks?